Cargando…
New Insights in PRRT: Lessons From 2021
Peptide receptor radionuclide therapy (PRRT) using radiolabeled somatostatin analogs has been used for over two decades for the treatment of well-differentiated neuroendocrine tumors (NETs), and the publication of the NETTER-1 trials has further strengthened its clinical use. However, many aspects o...
Autores principales: | Puliani, Giulia, Chiefari, Alfonsina, Mormando, Marilda, Bianchini, Marta, Lauretta, Rosa, Appetecchia, Marialuisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016202/ https://www.ncbi.nlm.nih.gov/pubmed/35450421 http://dx.doi.org/10.3389/fendo.2022.861434 |
Ejemplares similares
-
Metabolic and Endocrine Toxicities of Mitotane: A Systematic Review
por: Bianchini, Marta, et al.
Publicado: (2021) -
A Rare Case of Pituitary Melanoma Metastasis: A Dramatic and Prolonged Response to Dabrafenib-Trametinib Therapy
por: Mormando, Marilda, et al.
Publicado: (2020) -
Case Report: Ipilimumab-Induced Panhypophysitis: An Infrequent Occurrence and Literature Review
por: Barnabei, Agnese, et al.
Publicado: (2020) -
Neurological adverse events of mitotane in adrenocortical carcinoma: results of a pilot study
por: Mormando, Marilda, et al.
Publicado: (2023) -
Endocrine Disrupting Chemicals: Effects on Endocrine Glands
por: Lauretta, Rosa, et al.
Publicado: (2019)